Stay updated with breaking news from Elizabethl hougen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) issued its earnings results on Wednesday. The company reported ($0.06) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.78) by $0.72, MarketWatch Earnings reports. The company had revenue of $325.00 million during the quarter, compared to analysts’ expectations of $176.01 million. Ionis Pharmaceuticals had […] ....
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) shares gapped up before the market opened on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $44.35, but opened at $45.92. Ionis Pharmaceuticals shares last traded at $44.95, with a volume of 147,330 shares. The company reported ($0.06) earnings […] ....
WAINUA™ approved with launch underway; on track for EU and Canada approval decisions this year Positive Phase 3 olezarsen and donidalorsen data, preparing regulatory submissions for FCS and HAE,. ....
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) gapped up before the market opened on Wednesday following a better than expected earnings announcement. The stock had previously closed at $44.35, but opened at $45.92. Ionis Pharmaceuticals shares last traded at $44.95, with a volume of 147,330 shares changing hands. The company reported ($0.06) earnings per […] ....